CAIFX
Price
$70.64
Change
+$0.45 (+0.64%)
Updated
Apr 23 closing price
Net Assets
106.48B
KTRSX
Price
$8.50
Change
+$0.09 (+1.07%)
Updated
Apr 23 closing price
Net Assets
541.67M
Ad is loading...

CAIFX vs KTRSX

Header iconCAIFX vs KTRSX Comparison
Open Charts CAIFX vs KTRSXBanner chart's image
American Funds Capital Income Bldr F2
Price$70.64
Change+$0.45 (+0.64%)
VolumeN/A
Net Assets106.48B
DWS Global Income Builder S
Price$8.50
Change+$0.09 (+1.07%)
VolumeN/A
Net Assets541.67M
CAIFX vs KTRSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CAIFX vs. KTRSX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAIFX is a Buy and KTRSX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CAIFX has more cash in the bank: 106B vs. KTRSX (542M). KTRSX pays higher dividends than CAIFX: KTRSX (4.05) vs CAIFX (3.37). CAIFX was incepted earlier than KTRSX: CAIFX (17 years) vs KTRSX (20 years). KTRSX (0.74) is less costly to investors than CAIFX (0.38). CAIFX has a lower initial minimum investment than KTRSX: CAIFX (250) vs KTRSX (2500). CAIFX annual gain was more profitable for investors over the last year : 9.13 vs. KTRSX (-7.61). CAIFX return over 5 years is better than : 45.58 vs. KTRSX (15.33).
CAIFXKTRSXCAIFX / KTRSX
Total Expense Ratio0.380.7451%
Annual Report Gross Expense Ratio0.380.7451%
Fund Existence17 years20 years-
Gain YTD2.608-3.251-80%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets106B542M19,557%
Annual Yield % from dividends3.374.0583%
Returns for 1 year9.13-7.61-120%
Returns for 3 years13.910.255,466%
Returns for 5 years45.5815.33297%
Returns for 10 years33.1721.32156%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRI1.820.37
+25.52%
GRI Bio Inc.
MYO4.650.16
+3.56%
Myomo
DRS35.940.80
+2.28%
Leonardo DRS
DNLI14.870.27
+1.85%
Denali Therapeutics
PRTA9.590.05
+0.52%
Prothena Corp